FDA Warns Canadian Company for Marketing Device for Unapproved Uses
The Food and Drug Administration ordered a Canadian device manufacturer to stop marketing its device in the U.S. for unapproved uses, and renew its lapsed registration, in a warning letter dated March 13. According to FDA, Body, Mind & Soul,…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Inc. is marketing its “Celluderm,” a therapeutic massager, for uses as diverse as boosting the immune system, reduction of water retention, relief of headaches and restless legs, and breast cyst reduction. Marketing for new intended uses requires premarket notification to the agency. Without a premarket approval notification (PMA), its device is adulterated. The company did not complete a facility registration for 2013 either, FDA said.